Signal brief
What changed, the legal or scientific status today, and the unresolved questions.
For professional operators
Built for U.S. clinic, telehealth, pharmacy, laboratory, advisory, and investment teams that need the original source, current status, uncertainty, and next diligence step in one place.
What changed, the legal or scientific status today, and the unresolved questions.
The compounds, agencies, states, trials, and commercial risks your team actually monitors.
Direct links, publication dates, evidence class, limitations, and a visible update history.
The verification, counsel, partner, claims, or diligence question that should happen next.
Primary first. FDA, Federal Register, state boards, trial registries, and original research before commentary.
Status separated. Proposal, recommendation, approval, compounding eligibility, enforcement, and retail legality are not interchangeable.
Judgment shown. We state limitations, competing interpretations, and why the signal matters to your operation.
A narrow paid test
The founding pilot is a one-time $250 engagement designed to test whether maintained, source-linked monitoring saves your team enough review time or handoff friction to justify continuing.
Your team repeatedly checks changing FDA, Federal Register, trial, state-board, product, or partner records and needs the right change routed to the right owner.
You need legal opinions, patient-specific treatment guidance, product sourcing, a generic news feed, or a promise that monitoring will prevent enforcement.
Submit the decision and sources you monitor. We confirm fit in writing before payment and define the custom watchlist before the first brief.
Five U.S. operator teams
Four weekly briefs, one tailored watchlist, and a direct feedback loop. The purpose is to make one recurring decision process faster and more defensible.